From the Guidelines
The recommended dose of Omnivef (iron supplement) for a 1-month-old infant is typically 2-4 mg/kg/day of elemental iron, as stated in the Centers for Disease Control and Prevention guidelines 1. For most infants, this translates to approximately 1-2 mL of Omnivef drops daily, divided into 1-2 doses. The exact dosage should be determined by the infant's pediatrician based on the specific formulation of Omnivef being used and the infant's individual needs. Some key factors that influence the need for iron supplementation in infants include gestational age, birth weight, and maternal iron status, as discussed in a recent review on iron homeostasis during early infant development 1. Iron supplements should be administered between feedings, preferably with fruit juice (not milk) to enhance absorption. It's essential to note that routine iron supplementation is not recommended for all 1-month-old infants, particularly those who are exclusively breastfed or receiving iron-fortified formula, unless there is evidence of iron deficiency or the infant is at high risk, as highlighted in guidelines and reviews on iron requirements during early infant development 1. Iron is crucial for hemoglobin production, neurological development, and immune function in rapidly growing infants, but excessive iron can be harmful, so it's vital to store the supplement safely away from children and administer only the prescribed dose. Key considerations for iron supplementation in infants, including the benefits and risks, are discussed in recent studies and guidelines, emphasizing the importance of individualized recommendations based on the infant's specific needs and risk factors 1.
From the Research
Dosage of Omnivef in Infants
There is no direct information available in the provided studies regarding the dosage of Omnivef (iron supplement) in a 1-month-old infant.
Available Information on Iron Supplements
- The studies provided focus on the comparison of different iron supplements, such as ferrous sulfate, ferrous gluconate, and ferric citrate, in various populations, including toddlers, pregnant women, and patients with chronic kidney disease 2, 3, 4, 5.
- One study compares the efficacy of ferrous bisglycinate supplementation with other iron supplements in adults and children, including pregnant women and children 6.
- However, none of the studies provide specific dosage recommendations for infants as young as 1 month old.
Limitations
- The available studies do not provide sufficient information to determine the appropriate dosage of Omnivef in a 1-month-old infant.
- Further research is needed to establish safe and effective dosage guidelines for iron supplements in infants of this age group.